
Lifecore Biomedical, Inc.
NASDAQ:LFCR
Overview | Financials
Company Name | Lifecore Biomedical, Inc. |
Symbol | LFCR |
Currency | USD |
Price | 6.38 |
Market Cap | 236,221,414 |
Dividend Yield | 0% |
52-week-range | 3.68 - 7.99 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. James G. Hall |
Website | https://www.lifecore.com |
An error occurred while fetching data.
About Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD